Personalis, Inc. Long-Term Debt
Personalis, Inc. (PSNL) had Long-Term Debt of $18.02 million as of 2019-06-30, per its 10-Q filed 2019-08-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebtNoncurrent · last filed 2019-08-13
- 2019-06-30: Long-term Debt, Excluding Current Maturities $18.02M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2019-06-30 | $18.02M 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |